Boston Scientific News

Offerings include the catheters, guide wires, inflation devices, needles, and tubing used in heart stent procedures, pacemaker placements, and angioplasties.

Investors are always being told to diversify. Losses in one section of the portfolio can be overcome in other areas.

After a few years of somewhat depressed share prices, medical device makers seem are making a comeback.

The following post is provided exclusively to readers by the good folks at TheCorrectCall.com . I agree that medical and drug stocks are showing some resiliency... some even showing very bullish action, but ...

Angiotech Pharmaceuticals Inc. is packaging its assets not related to the Taxus coronary stent used in cardiac operations into a new subsidiary, Angiotech Pharmaceutical Interventions Inc.

Massachusetts lawmakers recently got an unusual gift from a lobbying group: small pieces of shower curtains wrapped in plastic baggies.

We believe FRE will face a more difficult funding environment in coming months than just a few months ago.

The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Abbott Laboratories shares rose Wednesday evening after regulators approved the use of one of its medical devices, and Dell Inc.

Main Category: Cardiovascular / Cardiology Also Included In: Clinical Trials / Drug Trials Article Date: 26 Jun 2008 Boston Scientific Corporation announced that the first patients were enrolled in the Cardiac ...

Boston Scientific Corp. has agreed to sell pieces of its investment portfolio through a pair of transactions that will raise a total $140 million before taxes and help pay off debt, but also force the medical ...

The management at Cordis seems to be loosing heart. The Johnson & Johnson subsidiary has had a round of significant turnover amongst its upper management in recent months with the latest announcement coming ...

Medical device maker Boston Scientific Corp. spent $400,000 lobbying the federal government in the first quarter, according to a recent disclosure form.

Fitch Ratings has changed its rating outlook on Natick-based Boston Scientific Corp.

Lima Memorial Hospital has changed a lot since James Tobin was born inside more than six decades ago.

Corporate Express, Inc. > Use of, or registration on, this site constitutes acceptance of our User Agreement and Privacy Policy .

Fitch Ratings raised the outlook on Boston Scientific Corp. to stable from negative given the medical device maker's progress in stabilizing its drug-coated stent and cardiac rhythm management device markets.

Jim Tobin, president and CEO of Natick-based Boston Scientific Corp. , will be head of the company "for the foreseeable future," the company said.

Holy crud! It would have been hard to believe back in April 1998 that a stock index tracking America's largest companies -- Schlumberger , Boston Scientific , Anheuser-Busch , et al -- would get beaten by a ...

Now it's sticking it to Boston Scientific in the courtroom. On Tuesday, a jury found that Boston Scientific's balloon catheters and stent delivery systems infringe on three of Medtronic's patents.